Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents
Author:
Affiliation:
1. Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK
2. Blizard Institute, Queen Mary University of London, London, UK
3. Royal London Hospital,Ambrose King Centre, Barts Health NHS Trust, London, UK
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1692811
Reference12 articles.
1. Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence
2. Molecular recognition in the human immunodeficiency virus capsid and antiviral design
3. Multiple roles of the capsid protein in the early steps of HIV-1 infection
4. Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein;International Journal of Molecular Sciences;2024-03-27
2. Dimeric Ankyrin with Inverted Module Promotes Bifunctional Property in Capturing Capsid to Impede HIV-1 Replication;International Journal of Molecular Sciences;2023-03-09
3. HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir;Frontiers in Microbiology;2022-04-12
4. Emerging Trends in the Long-Acting Antiretroviral Therapy: Current Status and Therapeutic Challenges;Current HIV Research;2021-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3